European Journal of Cancer
Volume 41, Issue 14 , Pages 2040-2059 , September 2005

Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors

  • Sara Gandini

      Affiliations

    • Department of Epidemiology and Biostatistics, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 02 57489819; fax: +39 02 57489922.
    • ,
  • Francesco Sera

      Affiliations

    • Molecular and Nutritional Epidemiology Unit, CSPO, Scientific Institute of Tuscany, Via di San Salvi 12, 50135 Florence, Italy
    • ,
  • Maria Sofia Cattaruzza

      Affiliations

    • Department of Public Health Sciences, University La Sapienza, Piazzale Aldo Moro 5, 00185 Rome, Italy
    • ,
  • Paolo Pasquini

      Affiliations

    • Laboratory of Clinical Epidemiology Istituto Dermopatico dell’Immaticolata (IDI) IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy
    • ,
  • Roberto Zanetti

      Affiliations

    • Piedmont Cancer Registry, CPO, Turin, Italy
    • ,
  • Cinzia Masini

      Affiliations

    • Istituto Dermopatico dell’Immaticolata (IDI) IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy
    • ,
  • Peter Boyle

      Affiliations

    • International Agency for Research on Cancer, Lyon, France
    • ,
  • Carmelo Francesco Melchi

      Affiliations

    • Istituto Dermopatico dell’Immaticolata (IDI) IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy

Received 11 February 2005 ,Accepted 16 March 2005.

References 

  1. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer. 2005;41:28–44
  2. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer. 2005;41:45–60
  3. Begg CB, Hummer A, Mujumdar U, et al. Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes Control. 2004;15:957–965
  4. Manson JE, Rexrode KM, Garland FC, et al. The case for a comprehensive national campaign to prevent melanoma and associated mortality. Epidemiology. 2000;11:728–734
  5. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124:869–871
  6. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev. 1987;
  7. SAS Institute Inc. SAS Windows version (8.02), Cary, NC; 1999.
  8. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188
  9. Copas JB, Shi JQ. A sensitivity analysis for publication bias in systematic reviews. Stat Meth Med Res. 2001;10:251–265
  10. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–1099
  11. Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634
  12. van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med. 2002;21:589–624
  13. Chen YT, Dubrow R, Holford TR, et al. Malignant melanoma risk factors by anatomic site: a case-control study and polychotomous logistic regression analysis. Int J Cancer. 1996;67:636–643
  14. Ford D, Bliss JM, Swerdlow AJ, et al. Risk of cutaneous melanoma associated with a family history of the disease. The International Melanoma Analysis Group (IMAGE). Int J Cancer. 1995;62:377–381
  15. Bliss JM, Ford D, Swerdlow AJ, et al. Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE). Int J Cancer. 1995;62:367–376
  16. Whiteman DC, Valery P, McWhirter W, et al. Risk factors for childhood melanoma in Queensland, Australia. Int J Cancer. 1997;70:26–31
  17. Youl P, Aitken J, Hayward N, et al. Melanoma in adolescents: a case-control study of risk factors in Queensland, Australia. Int J Cancer. 2002;98:92–98
  18. Grob JJ, Stern RS, McKie RM, et al. IARC monographs on the evaluation of carcinogenic risks to humans – solar and ultraviolet radiation. IARC Lyon, France; 1992.
  19. Gallagher R, Elwood JM. Sun exposure and the epidemiology of malignant melanoma. In:  Gallagher RP, Elwood  editor. Epidemiological aspects of cutaneous malignant melanoma. Kluwer academic; 1994;p. 16–66
  20. Cockburn M, Black W, McKelvey W, et al. Determinants of melanoma in a case-control study of twins (United States). Cancer Causes Control. 2001;12:615–625
  21. Green A, MacLennan R, Siskind V. Common acquired naevi and the risk of malignant melanoma. Int J Cancer. 1985;35:297–300
  22. Holly EA, Aston DA, Cress RD. Cutaneous melanoma in women II. Phenotypic characteristics and other host-related factors. Am J Epidemiol. 1995;141:934–942
  23. Holly EA, Kelly JW, Shpall SN, et al. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol. 1987;17:459–468
  24. Swerdlow AJ, English J, MacKie RM, et al. Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J (Clin Res Ed). 1986;292:1555–1559
  25. Walter SD, Marrett LD, From L, et al. The association of cutaneous malignant melanoma with the use of sunbeds and sunlamps. Am J Epidemiol. 1990;131:232–243
  26. Walter SD. Small sample estimation of log odds ratios from logistic regression and fourfold tables. Stat Med. 1985;4:437–444
  27. Green A, McCredie M, MacKie R, et al. A case-control study of melanomas of the soles and palms (Australia and Scotland). Cancer Causes Control. 1999;10:21–25
  28. Moore DH, Patterson HW, Hatch F, et al. Case-control study of malignant melanoma among employees of the Lawrence Livermore National Laboratory. Am J Ind Med. 1997;32:377–391
  29. Lindelof B, Sigurgeirssn B, Wallberg P, et al. Occurrence of other malignancies in 1973 patients with basal-cell carcinoma. J Am Acad Dermatol. 1991;25:245–248
  30. Osterlind A, Tucker MA, Hou-Jensen K, et al. The Danish case-control study of cutaneous malignant melanoma. I. Importance of host factors. Int J Cancer. 1988;42:200–206
  31. Holman CD, Armstrong BK. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. J Natl Cancer Inst. 1984;73:75–82
  32. Marghoob AA, Kopf AW, Rigel DS, et al. Risk of cutaneous malignant melanoma in patients with ‘classic’ atypical-mole syndrome. A case-control study. Arch Dermatol. 1994;130:993–998
  33. Halpern AC, Guerry D, Elder DE, et al. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study. Arch Dermatol. 1991;127:995–999
  34. MacKie RM, Freudenberger T, Aitchison TC. Personal risk-factor chart for cutaneous melanoma. Lancet. 1989;2:487–490see comments
  35. Dubin N, Moseson M, Pasternack BS. Epidemiology of malignant melanoma: pigmentary traits, ultraviolet radiation, and the identification of high-risk populations. Recent Results Cancer Res. 1986;102:56–75
  36. Elwood JM. Malignant melanoma in relation to moles, pigmentation and exposure to fluorescent and other lighting sources. Br J Cancer. 1986;53:65–74
  37. Marrett LD, King WD, Walter SD, et al. Use of host factors to identify people at high risk for cutaneous malignant melanoma. published erratum appears in Can Med Assoc J 1992 Dec 15;147(12):1764 CMAJ. 1992;147:445–453
  38. Grulich AE, Bataille V, Swerdlow AJ, et al. Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia. Int J Cancer. 1996;67:485–491
  39. White E, Kirkpatrick CS, Lee JA. Case-control study of malignant melanoma in Washington State. I. Constitutional factors and sun exposure. Am J Epidemiol. 1994;139:857–868
  40. Gallagher RP, Eldwood JM, Hill GB. Risk factor for cutaneous malignant melanoma in the Western Canada Melanoma Study. Recent Results Cancer Res. 1986;102:38–55
  41. Elwood JM, Whitehead SM, Davison J, et al. Malignant melanoma in England: risks associated with naevi, freckles, social class, hair colour, and sunburn. Int J Epidemiol. 1990;19:801–810
  42. Pfahlberg A, Kolmel KF, Gefeller O. Timing of excessive ultraviolet radiation and melanoma: epidemiology does not support the existence of a critical period of high susceptibility to solar ultraviolet radiation-induced melanoma. Br J Dermatol. 2001;144:471–475
  43. Shors AR, Solomon C, McTiernan A, et al. Melanoma risk in relation to height, weight, and exercise (United States). Cancer Causes Control. 2001;12:599–606
  44. Landi MT, Baccarelli A, Calista D, et al. Combined risk factors for melanoma in a Mediterranean population. Br J Cancer. 2001;85:1304–1310
  45. Graham S, Marshall J, Haughey B, et al. An inquiry into the epidemiology of melanoma. Am J Epidemiol. 1985;122:606–619
  46. Herzfeld PM, Fitzgerald EF, Hwang SA, et al. A case-control study of malignant melanoma of the trunk among white males in upstate New York. Cancer Detect Prev. 1993;17:601–608
  47. Weinstock MA, Colditz GA, Willett WC, et al. Recall (report) bias and reliability in the retrospective assessment of melanoma risk. Am J Epidemiol. 1991;133:240–245
  48. Lock-Andersen J, Drzewiecki KT, Wulf HC. The measurement of constitutive and facultative skin pigmentation and estimation of sun exposure in Caucasians with basal cell carcinoma and cutaneous malignant melanoma. Br J Dermatol. 1998;139:610–617
  49. Beitner H, Norell SE, Ringborg U, et al. Malignant melanoma: aetiological importance of individual pigmentation and sun exposure. Br J Dermatol. 1990;122:43–51
  50. Weinstock MA, Stryker WS, Stampfer MJ, et al. Sunlight and dysplastic nevus risk. Results of a clinic-based case-control study. Cancer. 1991;67:1701–1706
  51. Holman CD, Armstrong BK. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst. 1984;72:257–266
  52. Rodenas JM, Delgado-Rodriguez M, Herranz MT, et al. Sun exposure, pigmentary traits, and risk of cutaneous malignant melanoma: a case-control study in a Mediterranean population. Cancer Causes Control. 1996;7:275–283
  53. Nelemans PJ, Rampen FH, Ruiter DJ, et al. An addition to the controversy on sunlight exposure and melanoma risk: a meta-analytical approach. J Clin Epidemiol. 1995;48:1331–1342
  54. Freedman DM, Zahm SH, Dosemeci M. Residential and occupational exposure to sunlight and mortality from non-Hodgkin’s lymphoma: composite (threefold) case-control study. BMJ. 1997;314:1451–1455
  55. Dabkowski J, Omulecki A, Zalewska A. Identification of melanoma risk factors in the Polish population. Dermatol Surg. 1997;23:1039–1042
  56. Weinstock MA. Do sunscreens increase or decrease melanoma risk: an epidemiologic evaluation. J Investig Dermatol Symp Proc. 1999;4:97–100
  57. Holly EA. Cutaneous melanoma and oral contraceptives: a review of case-control and cohort studies. Recent Results Cancer Res. 1986;102:108–117
  58. Gefeller O, Hassan K, Wille L. Cutaneous malignant melanoma in women and the role of oral contraceptives. Br J Dermatol. 1998;138:122–124
  59. Huncharek M, Kupelnick B. Use of topical sunscreens and the risk of malignant melanoma: a meta-analysis of 9067 patients from 11 case-control studies. Am J Public Health. 2002;92:1173–1177
  60. Karagas MR, Stukel TA, Dykes J, et al. A pooled analysis of 10 case-control studies of melanoma and oral contraceptive use. Br J Cancer. 2002;86:1085–1092
  61. Stern RS. Malignant melanoma in patients treated for psoriasis with PUVA. Photodermatol Photoimmunol Photomed. 1999;15:37–38
  62. Wilkinson GS. Invited commentary: are low radiation doses or occupational exposures really risk factors for malignant melanoma. Am J Epidemiol. 1997;145:532–535
  63. Rhodes AR, Weinstock MA, Fitzpatrick TB, et al. Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals. JAMA. 1987;258:3146–3154
  64. Tucker MA, Boice JDJ, Hoffman DA. Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935–1982. Natl Cancer Inst Monogr. 1985;68:161–189
  65. Bentham G, Aase A. Incidence of malignant melanoma of the skin in Norway, 1955–1989: associations with solar ultraviolet radiation, income and holidays abroad. Int J Epidemiol. 1996;25:1132–1138
  66. Harrison RA, Haque AU, Roseman JM, et al. Socioeconomic characteristics and melanoma incidence. Ann Epidemiol. 1998;8:327–333
  67. Prota G. Melanins, melanogenesis and melanocytes: looking at their functional significance from the chemist’s viewpoint. Pigment Cell Res. 2000;13:283–293
  68. Zanetti R, Prota G, Napolitano A, et al. Development of an integrated method of skin phenotype measurement using the melanins. Melanoma Res. 2001;11:551–557
  69. Katsambas A, Nicolaidou E. Cutaneous malignant melanoma and sun exposure. Recent developments in epidemiology. Arch Dermatol. 1996;132:444–450
  70. Uter W, Pfahlberg A, Kalina B, et al. Inter-relation between variables determining constitutional UV sensitivity in Caucasian children. Photodermatol Photoimmunol Photomed. 2004;20:9–13
  71. Armstrong BK. How does sun exposure cause skin cancer – epidemiological perspective. In:  Hill D,  English DR,  Elwood J editor. Prevention of skin cancer, cancer causes – cancer prevention. vol. 3:New York: Kluwer Academic Publishers; 2004;p. 89–116
  72. Kahn HS, Tatham LM, Patel AV, et al. Increased cancer mortality following a history of nonmelanoma skin cancer. JAMA. 1998;280:910–912
  73. Frost CA, Green AC, Williams GM. The prevalence and determinants of solar keratoses at a subtropical latitude (Queensland, Australia). Br J Dermatol. 1998;139:1033–1039
  74. Siskind V, Aitken J, Green A, et al. Sun exposure and interaction with family history in risk of melanoma, Queensland, Australia. Int J Cancer. 2002;97:90–95
  75. Whiteman DC, Watt P, Purdie DM, et al. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst. 2003;95:806–812
  76. Rivers JK. Is there more than one road to melanoma. Lancet. 2004;363:728–730
  77. Whiteman DC, Parsons PG, Green AC. p53 expression and risk factors for cutaneous melanoma: a case-control study. Int J Cancer. 1998;77:843–848
  78. Gellin GA, Kopf AW, Garfinkel L. Malignant melanoma. A controlled study of possibly associated factors. Arch Dermatol. 1969;99:43–48
  79. Klepp O, Magnus K. Some environmental and bodily characteristics of melanoma patients. A case-control study. Int J Cancer. 1979;23:482–486
  80. MacKie RM, Aitchison T. Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in scotland. Br J Cancer. 1982;46:955–960
  81. Beral V, Evans S, Shaw H, et al. Cutaneous factors related to the risk of malignant melanoma. Br J Dermatol. 1983;109:165–172
  82. Lew RA, Sober AJ, Cook N, et al. Sun exposure habits in patients with cutaneous melanoma: a case control study. J Dermatol Surg Oncol. 1983;9:981–986
  83. Elwood JM, Gallagher RP, Hill GB, et al. Pigmentation and skin reaction to sun as risk factors for cutaneous melanoma: Western Canada Melanoma Study. Br Med J (Clin Res Ed). 1984;288:99–102
  84. Dubin N. Epidemiology of malignant melanoma: pigmentary traits,ultraviolet radiation and identification of high-risk populations. Recent Results Cancer Res. 1986;102:56–75
  85. Holman CD, Armstrong BK, Heenan PJ. Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst. 1986;76:403–414
  86. Ammannatti P, Lombardi P, Brogelli L. (Case-control study of various phenotypic characteristics of patients with cutaneous melanoma) Studio caso controllo di alcune caratteristiche fenotipiche di pazienti affetti da melanoma cutaneo (MC). G Ital Dermatol Venereol 1987.
  87. Bell CMJ, Genkinson CM, Murrels TJ. Aetiological factors in cutaneous malignant melanomas seen at a UK skin clinic. J Epidemiol Commun Health. 1987;41:306–311
  88. Cristofolini M, Franceschi S, Tasin L, et al. Risk factors for cutaneous malignant melanoma in a northern Italian population. Int J Cancer. 1987;39:150–154
  89. Holly EA. A number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol. 1987;459–468Abstract
  90. Bain C, Colditz GA, Willett WC, et al. Self-reports of mole counts and cutaneous malignant melanoma in women: methodological issues and risk of disease. Am J Epidemiol. 1988;127:703–712
  91. Garbe C, Kruger S, Stadler R, et al. Markers and relative risk in a German population for developing malignant melanoma. Int J Dermatol. 1989;28:517–523
  92. Grob JJ, Gouvernet J, Aymar D, et al. Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer. 1990;66:387–395
  93. Augustsson A, Stierner U, Rosdahl I, et al. Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in a Swedish population. Acta Derm Venereol. 1991;71:518–524
  94. Weiss J, Bertz J, Jung EG. Malignant melanoma in southern Germany: different predictive value of risk factors for melanoma subtypes. Dermatologica. 1991;183:109–113
  95. Zaridze D, Mukeria A, Duffy S. Risk factors for skin Melanoma in Moscow (letter. Int J Cancer. 1992;52:159–161
  96. Zanetti R, Franceschi S, Rosso S, et al. Cutaneous melanoma and sunburns in childhood in a southern European population. Eur J Cancer. 1992;28A:1172–1176
  97. Rosso S, Zanetti R, Pippione M, et al. Parallel risk assessment of melanoma and basal cell carcinoma: skin characteristics and sun exposure. Melanoma Res. 1998;8:573–583
  98. Dunn-Lane J, Herity B, Moriarty MJ, et al. A case control study of malignant melanoma. Irish Med J. 1993;86:57–59
  99. Autier P, Dore JF, Lejeune F, et al. Cutaneous malignant melanoma and exposure to sunlamps or sunbeds: an EORTC multicenter case-control study in Belgium, France and Germany. EORTC Melanoma Cooperative Group. Int J Cancer. 1994;58:809–813
  100. Garbe C, Buttner P, Weiss J, et al. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol. 1994;102:695–699
  101. Westerdahl J, Olsson H, Masback A, et al. Is the use of sunscreens a risk factor for malignant melanoma. Melanoma Res. 1995;5:59–65
  102. Bataille V, Bishop JA, Sasieni P, et al. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer. 1996;73:1605–1611
  103. Frish M, Hjalgrim H, Holsen JH. Risk for subsequent cancer after diagnosis of basal-cell carcinoma.A population based , epidemiologic study. Ann Int Med. 1996;125:815–821
  104. Tucker MA, Halpern A, Holly EA, et al. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. see comments JAMA. 1997;277:1439–1444
  105. Wolf P, Quehenberger F, Mullegger R, et al. Phenotypic markers, sunlight-related factors and sunscreen use in patients with cutaneous melanoma: an Austrian case-control study. Melanoma Res. 1998;8:370–378
  106. Carli P, Massi D, Santucci M, et al. Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: results from a case-control study. J Am Acad Dermatol. 1999;40:549–557
  107. Tabenkin H, Tamir A, Sperber AD, et al. A case-control study of malignant melanoma in Israeli kibbutzim. Isr Med Assoc J. 1999;1:154–157
  108. Walter SD, King WD, Marrett LD. Association of cutaneous malignant melanoma with intermittent exposure to ultraviolet radiation: results of a case-control study in Ontario, Canada. Int J Epidemiol. 1999;28:418–427
  109. Naldi L, Lorenzo IG, Parazzini F, et al. Pigmentary traits, modalities of sun reaction, history of sunburns, and melanocytic nevi as risk factors for cutaneous malignant melanoma in the Italian population: results of a collaborative case-control study. Cancer. 2000;88:2703–2710
  110. Kaskel P, Sander S, Kron M, et al. Outdoor activities in childhood: a protective factor for cutaneous melanoma? Results of a case-control study in 271 matched pairs. Br J Dermatol. 2001;145:602–609
  111. Loria D, Matos E. Risk factors for cutaneous melanoma: a case-control study in Argentina. Int J Dermatol. 2001;40:108–114
  112. Bakos L, Wagner M, Bakos RM, et al. Sunburn, sunscreens, and phenotypes: some risk factors for cutaneous melanoma in southern Brazil. Int J Dermatol. 2002;41:557–562
  113. Green A, Whiteman D, Frost C, Battistutta D. Sun exposure, skin cancers and related skin conditions. J Epidemiol. 1999;9:S7–S13

PII: S0959-8049(05)00545-9

doi: 10.1016/j.ejca.2005.03.034

European Journal of Cancer
Volume 41, Issue 14 , Pages 2040-2059 , September 2005

Article Tools

* Image Usage & Resolution